fucose has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alley, WR; Goetz, JA; Hussein, A; Mann, BF; Matei, DE; Mechref, Y; Menning, N; Novotny, MV; Svoboda, M; Vasseur, JA | 1 |
| Carrero, JJ; Deng, Y; Du, X; Li, L; Li, Z; Lin, H; Shen, N; Tang, Q; Wang, K; Wang, N; Wang, W; Wu, T | 1 |
2 other study(ies) available for fucose and imatinib mesylate
| Article | Year |
|---|---|
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Carbohydrate Sequence; Case-Control Studies; Docetaxel; Female; Fucose; Glycomics; Humans; Imatinib Mesylate; Immunoglobulin G; Methylation; Ovarian Neoplasms; Piperazines; Polysaccharides; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Taxoids | 2012 |
Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
Topics: Animals; Dialysis Solutions; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fucose; Fucosyltransferases; Glucose; Imatinib Mesylate; Male; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; Receptors, Transforming Growth Factor beta; RNA Interference; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor beta1 | 2018 |